nelfinavir has been researched along with Leishmania Infection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvar, J; Cañavate, C; Dagger, F; Moreno, J; Rangel, A; Saugar, JM; Valdivieso, E | 1 |
| Branquinha, MH; d'Avila-Levy, CM; Pedroso e Silva, CM; Santos, AL; Santos, LO; Vitório, BS | 1 |
2 other study(ies) available for nelfinavir and Leishmania Infection
| Article | Year |
|---|---|
Effects of HIV aspartyl-proteinase inhibitors on Leishmania sp.
Topics: Animals; Aspartic Acid Proteases; Cell Line; Cells, Cultured; Dose-Response Relationship, Drug; HIV Infections; HIV Protease Inhibitors; Humans; Leishmania infantum; Leishmania mexicana; Leishmaniasis; Macrophages; Mice; Monocytes; Nelfinavir; Saquinavir | 2010 |
Nelfinavir is effective in inhibiting the multiplication and aspartic peptidase activity of Leishmania species, including strains obtained from HIV-positive patients.
Topics: Antiprotozoal Agents; Aspartic Acid Proteases; Colorimetry; Fluorometry; HIV Infections; Humans; Leishmania; Leishmaniasis; Microbial Viability; Nelfinavir; Oligopeptides; Saquinavir; Tetrazolium Salts; Thiazoles | 2013 |